RemSleep Holdings (RMSL) EBIT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.25% |
| Sep 30, 2025 | -108.38% |
| Jun 30, 2025 | -2.98% |
| Mar 31, 2025 | -10.59% |
| Dec 31, 2024 | -14.58% |
| Sep 30, 2024 | -11.54% |
| Jun 30, 2024 | 32.31% |
| Mar 31, 2024 | -20.02% |
| Dec 31, 2023 | -35.95% |
| Sep 30, 2023 | -2.23% |
| Jun 30, 2023 | 6.33% |
| Mar 31, 2023 | -8.85% |
| Dec 31, 2022 | -37.10% |
| Sep 30, 2022 | -22.88% |
| Jun 30, 2022 | -3.92% |
| Mar 31, 2022 | 2.18% |
| Dec 31, 2021 | 7.31% |
| Sep 30, 2021 | -220.79% |
| Jun 30, 2021 | -111.00% |
| Mar 31, 2021 | -29.12% |
| Dec 31, 2020 | -74.76% |
| Sep 30, 2020 | -202.34% |
| Jun 30, 2020 | -24.28% |
| Mar 31, 2020 | -18.37% |
| Dec 31, 2019 | -1.74% |
| Dec 31, 2018 | 39.80% |
| Sep 30, 2018 | -3.75% |
| Jun 30, 2018 | 17.60% |
| Mar 31, 2018 | 6.86% |
| Dec 31, 2017 | 20.13% |
| Sep 30, 2017 | 25.31% |
| Jun 30, 2017 | 15.35% |
| Mar 31, 2017 | -58.50% |
| Dec 31, 2016 | -49.16% |
| Jun 30, 2016 | 45.82% |
| Mar 31, 2016 | -6.62% |
| Dec 31, 2015 | 83.61% |
| Sep 30, 2015 | 76.65% |